In the previous post, we discussed booster vaccination: giving an extra shot does not automatically mean more reliable protection; every booster should have a clear protective goal.
 
  Once it is determined that “this shot is needed,” another question immediately arises:
 
  When should it be given?
 
  In production, vaccination schedules are usually presented by fixed ages: 7 days of age, 14 days of age, 21 days of age, or an interval of 3 weeks or 4 weeks between two inactivated vaccines. Over time, these ages can easily be mistaken for “standard answers”.
 
  But existing research suggests that a reasonable interval between two immunizations is not simply a matter of choosing a fixed number of days.
 
  What really needs to be considered is:
 
  the extent to which the immune response to the previous immunization has developed, whether the two vaccines interact, the flock’s current immune status, and when protection will actually be needed in the next stage.
 
  01|Protection does not develop immediately after vaccination
 
A single vaccination does not mean that immune protection immediately reaches a stable level.
 
Tian Lina continuously tracked antibody changes after immunization with the H5+H7 bivalent inactivated vaccine at 5 layer farms. The results showed that the average H5 HI value was approximately 2.5–3.1 log? on day 7 post-immunization, rose to 4.6–5.2 log? on day 14, reached 6.2–7.1 log? on day 21, and remained at a relatively high level on day 28 [1].
 
The most valuable point of this set of data is not that it tells us that “inactivated vaccines must be given at intervals of 21 or 28 days,” but that it very clearly illustrates:
 
It takes time for the immune response to become fully established after vaccination.
 
  Therefore, the time between two immunizations cannot simply be understood as “the sooner the next dose is given, the sooner protection builds up.”
 
  Especially when there is already a weak immune foundation, if the immune response to the previous immunization is still developing, it is worth carefully considering when the next stimulus is introduced.
 
  Therefore, the “interval of a few days” shown on the schedule should first be based on an understanding of the process of the immune response to the previous immunization.
 
  02|For some vaccine combinations, an interval of a few days really can affect the outcome
 
  Timing affects not only the establishment of an individual vaccine response; time-related interactions may also occur between different vaccines.
 
  Zheng Houjing et al. studied the effects of different intervals between administration of fowlpox live attenuated vaccine and Newcastle disease Clone30 live attenuated vaccine. The intervals tested were the same day, 5 days, 10 days, and 15 days, with a Newcastle disease-only immunization group as the control. The results showed that the mean HI titer in the Newcastle disease-only immunization group was 8.35 log?, compared with 7.95 log? in the same-day administration group. At intervals of 5 days and 10 days, the titers were 7.00 and 7.50 log?, respectively; at an interval of 15 days, the titer rose to 8.20 log?[2].
 
  In this specific combination, the effect on ND antibodies was actually more pronounced with an interval of 5–10 days, while after 15 days it gradually approached the level of the single-vaccine immunization group.
 
  This points to a very important issue:
 
  Immune intervals are not simply a matter of “the closer together, the worse; the farther apart, the better”; different vaccine combinations may have their own timing patterns.
 
  In 2026 year, Wen et al. further compared protection against challenge after administration of live IBDV and live avian reovirus (ARV) vaccines on the same day or at intervals of 3, 5, or 7 days. The results showed that protection on the IBDV side remained basically stable, while the ARV side was significantly affected: the protection rate with vaccination alone was approximately 86.7%–93.3%; it fell to 46.7% with same-day vaccination, was 66.7% at an interval of 3 days, and gradually recovered to nearly the level of vaccination alone at 5 and 7 days[3].
 
  What is particularly instructive about this study is that it suggests:
 
  Interference between vaccines may not be symmetrical.
 
  The fact that one vaccine’s protection shows no obvious change does not mean there is no interaction within the overall combination.
 
  Of course, “5 days” here applies only to this specific live vaccine combination. What is truly worth applying in production is the principle that timing may affect the final immune response, not copying the specific number of days.
 
  03|The interval is not necessarily better the longer it is
 
  Since short intervals may cause interference, would it be better to space the two immunizations as far apart as possible?
 
  Neither is it.
 
  Methner studied booster schedules for a live Salmonella vaccine in chickens. After primary vaccination at 1 days of age, booster doses were given at 28, 35, and 42 days of age, followed by challenge at 56 days of age. All groups with different booster timings achieved good immune responses and protection[4].
 
  This indicates that, in this vaccine system, booster timing has some flexibility; effectiveness is not limited to one specific date.
 
  In their study of the prime-boost strategy for a recombinant H5 hemagglutinin protein vaccine, S?czyńska et al. also observed that different immunization intervals affected the final antibody response. In comparisons of boosting at 2 versus 4 weeks in commercial chickens, and at 4 versus 6 weeks in layer-type chickens, the longer-interval groups achieved better neutralizing antibody responses with this vaccine system[5].
 
  Therefore, existing studies collectively suggest:
 
  The goal in setting the interval between immunizations is not to find the “shortest” or “longest” interval, but to identify a more appropriate immunization window based on the specific vaccine, the flock’s baseline status, and the protection objectives.
 
  In other words, timing itself is a decision variable in the immunization program.
 
  04|Long-term laying hens and breeding chickens should not keep receiving boosters at the same interval indefinitely.
 
  For laying hens and breeding hens, this issue is even more relevant.
 
  Because their production cycles are much longer than those of broiler chickens, the immune status of the flock continues to change over dozens of weeks or even longer.
 
  Zhao Quanxing et al. continuously tracked antibody changes following immunization with inactivated Newcastle disease vaccine in 3 batches of Hy-Line Brown laying hens. They observed that, as age increased and previous immunizations accumulated, the duration for which high antibody levels were maintained generally increased[6]. This suggests that the need for the next booster may not be the same for the same flock at different production stages.
 
  Ren Rongqing et al. compared 3 H5 avian influenza immunization schedules in 9000 Lohmann laying hens: 15-35-110 days of age, 20-45-110 days of age, and 25-60-110 days of age. At 110 days of age, the mean HI levels for the 3 schedules were approximately 5.50, 6.13, and 8.30 log?, respectively; the 25-60-110-days-of-age schedule performed better in the later period[7].
 
  This field study cannot simply be summed up as “an interval of 35 days is best,” because 3 programs changed both the age at the first vaccination and the timing of subsequent boosters. Its practical production takeaway is:
 
  The vaccination interval must be evaluated in the context of the full program and the flock’s immune background.
 
  For long-cycle flocks, programs cannot mechanically repeat “one shot every so many days” indefinitely. As prior immunization accumulates and antibody duration and risks in the next stage change, what often needs adjustment is the timing of the next shot.
 
  Practical production takeaway
 
  On-site, to determine when the next vaccination should be given, start by asking four questions:
 
  Has the immune response to the previous vaccination been established? Is there significant interference between the two vaccines? What is the current immune status of the flock? When will protection actually be needed in the next stage?
 
  Therefore, a good interval between vaccinations is neither as short as possible for extra security nor as long as possible in the name of science. Instead, it should:
 
  Allow the previous vaccination to take full effect while ensuring the next vaccination falls within the most valuable time window.
 
  A schedule tells us “when to do it,” but more mature immunization decisions should go further and answer:
 
  Why at this time?
 
  Summary
 
  A good interval between immunizations is neither shorter for greater safety nor longer for greater scientific rigor. Instead, it allows the previous immunization to take full effect while ensuring the next one falls within the most valuable time window.
 
  In the next installment, we’ll take another step forward:
 
  When multiple vaccines need to be incorporated into the same immunization program, what exactly do multivalent, polyvalent, and combined immunization truly optimize?
 
  References
 
  [1] Tian Lina. Optimization of Highly Pathogenic Avian Influenza Vaccine Immunization Programs and Clinical Applications [D]. Harbin: Northeast Agricultural University, [2021].
 
  [2] Zheng Houjing, Dang Chunhua, Liu Jinchuan. Experimental observation of interference with Newcastle disease hemagglutination inhibition antibodies following immunization with fowlpox vaccine and Newcastle disease vaccine[J]. Chinese Journal of Preventive Veterinary Medicine, 2000, 22(2): 106-108.
 
  [3] WEN J, LI M, LONG Y, et al. Assessment of immunological interference between live infectious bursal disease virus and avian reovirus vaccines in SPF chickens[J]. Animals, 2026, 16(4): 690.
 
  [4] METHNER U. Immunisation of chickens with live Salmonella vaccines—Role of booster vaccination[J]. Vaccine, 2018, 36(21): 2973-2977.
 
  [5] S?CZY?SKA V, ROMANIK-CHRU?CIELEWSKA A, FLORYS K, et al. Prime-boost vaccination with a novel hemagglutinin protein produced in bacteria induces neutralizing antibody responses against H5-subtype influenza viruses in commercial chickens[J]. Frontiers in Immunology, 2019, 10: 2006.
 
  [6] Zhao Quanxing, Yang Huiling, Liu Fangna, et al. Investigation of the immunization interval for Newcastle disease inactivated vaccine[J]. China Animal Husbandry & Veterinary Medicine, 2011, 38(10): 238-241.
 
  [7] Ren Rongqing, Wang Desheng, Huang Bo, et al. Optimization of the immunization program for highly pathogenic avian influenza vaccines in laying hens[J]. China Poultry, 2015, 37(11): 64-65.